Peter J Harrington

Title: **Peter J. Harrington: Innovating Antineoplastic Agents**

Introduction

Peter J. Harrington is a prominent inventor based in Endicott, New York, known for his significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Harrington's work focuses on developing innovative compounds that serve as antineoplastic agents.

Latest Patents

Harrington's latest patents involve the creation of pyrido[2,3-]pyrimidine derivatives, specifically 2,4-diamino- and 2-amino-4-hydroxy- derivatives of N-(4-[2-(pyrido[2,3-d]pyrimidin-6-yl)alkyl]benzoyl)-L-glutamic acids. These compounds are recognized for their potential in cancer treatment. The preparation of these compounds involves the hydrolytic or hydrogenolytic removal of carboxylic acid protecting groups from the corresponding protected glutamic acid derivatives. A typical embodiment highlighted in his patents is N-(4-[2-(2-amino-4-hydroxy-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl)-L-glutamic acid.

Career Highlights

Peter J. Harrington is affiliated with Princeton University, where he has made a substantial impact in research and innovation. His career is marked by a commitment to advancing the pharmaceutical sciences, particularly in the development of new therapeutic agents.

Collaborations

Throughout his career, Harrington has collaborated with esteemed professionals in the field, including Edward C. Taylor and George P. Beardsley. These collaborations have further enriched his innovative approach and contributed significantly to advancements in antineoplastic research.

Conclusion

Peter J. Harrington exemplifies the essence of innovation in the pharmaceutical industry. His patents reflect not only his expertise but also a dedication to improving treatment options for cancer patients. As he continues to work within the framework of Princeton University, his future contributions to science and medicine remain highly anticipated.